Safety and Efficacy Pilot Trial of the Anti-Viral and Anti-Tumor Activity of Velcade Combined with (R)ICE in Subjects with EBV and/or HHV-8 Positive Relapsed/ Refractory AIDS-Associated Non-Hodgkin's Lymphoma
Phase of Trial: Phase I/II
Latest Information Update: 06 Dec 2016
At a glance
- Drugs Bortezomib (Primary) ; Carboplatin; Dexamethasone; Etoposide; Ifosfamide; Rituximab
- Indications Non-Hodgkin's lymphoma
- Focus Adverse reactions; Therapeutic Use
- 06 Dec 2016 Results presented at the 58th Annual Meeting and Exposition of the American Society of Hematology.
- 07 May 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 02 Feb 2015 Planned End Date changed from 1 Jul 2015 to 1 Apr 2015 according to ClinicalTrials.gov record.